ARF3 and breast carcinoma: In breast cancers, ARF3 upregulation was reported as associated with pro-proliferative functions (Huang et al., 2019), while in gastric cancer, similar to our findings in prostate cells, ARF3 suppressed proliferative function and in vivo tumorigenesis (Liu et al., 2021).